Quick Links
WHEN IT COMES TO BRD,
PREVENTION IS GENERALLY MORE COST EFFECTIVE THAN TREATMENT
Bovine Respiratory Disease (BRD), also known as "shipping fever", is a costly disease that affects cattle throughout the United States across all segments of the industry. While there are many factors that contribute to its development and progression, decades of research have identified five viruses and five bacteria as the predominate disease-causing pathogens associated with the complex disease. Read
BRD Associated Viruses
- Parainfluenza 3 (PI3)
- Bovine Viral Diarrhea (BVD) Type 1
- Bovine Viral Diarrhea (BVD) Type 2
- Bovine Respiratory Syncytial Virus (BRSV)
- Bovine Rhinotracheitis (IBR)
BRD Associated Bacteria
- Mannheimia (Pasteurella) haemolytica Type A1
- Mannheimia (Pasteurella) haemolytica Type A6
- Pasteurella multocida
- Mycoplasma bovis
- Haemophilus somnus
There are a lot of variables that need to be considered when building the right vaccination protocol for your operation. Making sure your vaccine protocol is covering the most common viral and bacterial contributors to the disease is a good start. Ultimately, at the end of the day, it is important to choose the right products, give them the right way and at the right time.
All of our commercial cattle vaccines were developed specifically for stocker and feeder cattle to provide protection against all 10 of the most common BRD-causing pathogens. They are available in a variety of different combinations and presentations to meet your operations’ specific needs.
We recommend working with your veterinarian to build an effective vaccination protocol specifically for your operation.
Modified-Live Virus (MLV) Vaccines
A full line of viral vaccines that bring bovine MLV vaccine quality assurance and animal safety to new levels.
NO SMOKE & MIRRORS.
JUST SOLID SCIENCE.
Stimulator® vaccines were designed to stimulate a strong, protective immune response in stocker and feeder cattle against the five most common viral pathogens associated with Bovine Respiratory Disease (BRD):
- Infectious Bovine Rhinotracheitis (IBR)
- Bovine Viral Diarrhea Type 1 (BVD I)
- Bovine Viral Diarrhea Type 2 (BVD II)
- Bovine Respiratory Syncytial Virus (BRSV)
- Parainfluenza3 (PI3)
DOWNLOAD | STIMULATOR DETAILER
Killed Bacterial Vaccines
Effective bacterins developed to protect cattle against the most prevalent bacterial pathogens associated with BRD.
PROTECT YOUR CATTLE AND YOUR
BOTTOM LINE.
Our PRO-BAC™ vaccine line was developed specifically for stocker and feeder cattle and offers the most complete protection against five of the most common BRD-causing bacteria:
- Mannheimia haemolytica Type A1 (MhA1)
- Mannheimia haemolytica Type A6 (MhA6)
- Pasteurella multocida (Pm)
- Histophilus somni / Haemophilus somnus (Hs)
- Salmonella typhimurium (St)
No other vaccines available on the market can say the same.
All of the PRO-BAC vaccines are powered by our proprietary adjuvant Reveal ATS™. Learn more about the Reveal ATS Advantage
DOWNLOAD PRO-BAC - FEATURES, BENEFITS & COMPARISONS TO OTHER PRODUCTS PRO-BAC - OVERVIEW & IMPORTANCE OF PREVENTION PRO-BAC ADMINISTRATION GUIDE
Killed Mycoplasma Bovis Vaccine
The first fully licensed USDA vaccine that protects cattle against one of the most costly bacteria - Mycoplasma bovis.
DEALING WITH HIGH PULL RATES, POOR TREATMENT RESPONSE AND SWOLLEN JOINTS IN RECENTLEY WEANED CALVES?
YOUR VACCINE PROTOCOL MAY BE MISSING A KEY PIECE.
Mycoplasma bovis is one of the most prevalent of all the bacterial pathogens affecting young cattle during periods of elevated stress such as weaning and transportation. In general, the higher the “risk classification” of a particular group of cattle the greater the possibility of a Mycoplasma problem. Read
The typical “myco” infections begin to show up about 3 weeks after exposure and can cause respiratory disease as well as crippling arthritis. Due to it’s extremely small cell size and lack of a ridged cell wall, many antibiotics are rendered ineffective against M. bovis resulting in increased pull rates, poor treatment response and unusually high death rates.
MYCO-BAC® was the first fully licensed Mycoplasma bovis (also referred to as ‘Mycoplasma’ or ‘Myco’) vaccine approved by the USDA in 2002. It was originally developed by the team at Texas Vet Lab, Inc. following years of clinical observation and diagnostic/laboratory research as well as significant experience producing effective autogenous vaccines for feedlot and stocker veterinarians and consultants from across the country.
MYCO-BAC is powered by our proprietary adjuvant Reveal ATS™. Learn more about the Reveal ATS™ Advantage
DOWNLOAD | MYCO-BAC DETAILER
The Benefits of Vaccinating with MYCO-BAC
COST SAVINGS
When it comes to Mycoplasma bovis, prevention is almost always cheaper than treatment. Not only will a myco infection negatively impact cattle’s’ performance by keeping them off feed and water, effective treatment options are limited which often leads to high labor and drug expenses.
REDUCED MORBIDITY & MORTALITY
Field trials coupled with expansive experience and understanding of the disease support that giving MYCO-BAC, according to the labeled 3-dose regiment administered on days 0, 7 and 14, will reduce morbidity and mortality as well as increase treatment response success in vaccinated cattle.
EFFECTIVE
Our unique manufacturing process combines quality bacterial antigen with our proprietary adjuvant system (Reveal ATS™) to create a strong, specific immune response to prevent and control respiratory disease due to M. bovis.
Learn more about the Reveal ATS™ Advantage
Bimeda USA
Bimeda® Biologicals
1702 North Bell Street,
San Angelo, Texas
76903
Phone: 1 800 284 8403
RELEVANT
QUALITY
SAFE
EFFICACY
CONVENIENCE
VERSATILITY